Net product revenues for Xtampza ER were $2.2 million for the 2017 Quarter compared to none for the 2016 Quarter. Net product revenues increased by 67% for the 2017 Quarter compared to the quarter ended December 31, 2016. Only losing $29M per month now, nice work dummy!
there were no sales in Q1 2016! Drug was launched until June 16, 2016. That's a bad statistic to quote.
Says the guy who likely lives in a state where Medicaid covers every product! You guys are the best sales reps at every company! lol